( As on 19/06/2026 13:01)
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 19, 2026, titled ""Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg"".